相关实验视频

Updated: Jul 19, 2025

Using CRISPR/Cas9 Gene Editing to Investigate the Oncogenic Activity of Mutant Calreticulin in Cytokine Dependent Hematopoietic Cells

Using CRISPR/Cas9 Gene Editing to Investigate the Oncogenic Activity of Mutant Calreticulin in Cytokine Dependent Hematopoietic Cells

Published on: January 5, 2018

在使用CRISPR/Cas9基因组编辑的人类神经母细胞细胞中加速亡和下调的FMRP

Rong Zhang^1,2, Huifen Xu³, Jin Lu¹

¹Department of Gynecology and Obstetrics, the Second Affiliated Hospital of Soochow University, Suzhou, 215004, China.

Iranian journal of public health

|August 8, 2023

概括

CRISPR/Cas9基因编辑成功地准了人类细胞中的FMR1基因,为脆弱X综合征 (FXS) 提供了潜在的治疗方法. 这种方法减少了FMRP蛋白和改变细胞周期,支持其用于FXS治疗的可行性.

科学领域:

遗传学是一个遗传学.
分子生物学分子生物学
神经科学是一个神经科学.

背景情况:

脆弱X综合征 (FXS) 是一种导致智力障碍的遗传疾病,通常是由于FMR1基因的CGG重复扩张.
这种突变导致FMR1基因转录和大脑中的FMRP蛋白水平降低.
CRISPR/Cas9系统为FXS提供了一个潜在的基因治疗策略.

研究的目的:

评估使用CRISPR/Cas9系统用于FXS基因治疗的可行性.
在培养的人类神经母细胞瘤细胞中准FMR1基因的5'-UTR.

主要方法:

使用PCR和DNA克隆构建等离子体.
通过西方斑点和流细胞测量来评估CRISPR/Cas9功能.
使用双尾未配对学生t测试进行统计分析.

主要成果:

针对FMR1的CRISPR/Cas9向导致细胞周期阶段 (G1,S,G2/M) 的显著差异.
绝杀细胞中的亡加速.
与对照细胞相比,FMRP表达在淘汰细胞中显著下调.

结论:

这项研究增强了对FMRP功能和神经细胞中FMR1基因分子机制的理解.
这些发现表明,CRISPR/Cas9基因编辑作为治疗脆弱X综合征的治疗方法的可行性.

关键词:

与CRISPR相关的蛋白质9是CRISPR相关的蛋白质9.脆弱的X综合征脆弱的X综合征基因编辑基因编辑

更多相关视频

Highly Efficient Gene Disruption of Murine and Human Hematopoietic Progenitor Cells by CRISPR/Cas9

Highly Efficient Gene Disruption of Murine and Human Hematopoietic Progenitor Cells by CRISPR/Cas9

Published on: April 10, 2018

CRISPR Gene Editing Tool for MicroRNA Cluster Network Analysis

CRISPR Gene Editing Tool for MicroRNA Cluster Network Analysis

Published on: April 25, 2022

相关概念视频

CRISPR

CRISPR

Genome editing technologies allow scientists to modify an organism’s DNA via the addition, removal, or rearrangement of genetic material at specific genomic locations. These types of techniques could potentially be used to cure genetic disorders such as hemophilia and sickle cell anemia. One popular and widely used DNA-editing research tool that could lead to safe and effective cures for genetic disorders is the CRISPR-Cas9 system. CRISPR-Cas9 stands for Clustered Regularly Interspaced...

CRISPR/Cas9 Genome Editing

CRISPR/Cas9 Genome Editing

The CRISPR-Cas system serves as a bacterial defense mechanism against invading genetic elements such as viruses and plasmids, forming the foundation for its adaptation as a powerful genome-editing tool. Originally discovered in prokaryotes, this system has been repurposed to revolutionize genetic engineering across a wide range of organisms, including plants, animals, and humans. The core component, Cas9, is an endonuclease derived from Streptococcus pyogenes, capable of introducing...